logo

IXHL

Incannex Healthcare·NASDAQ
--
--(--)
--
--(--)
5.12 / 10
Netural

IXHL's fundamental score of 5.1/10 reflects a balanced but not outstanding profile. Key strengths include a healthy interest-coverage ratio (42.48) and positive revenue-to-market value (-0.257), while concerns linger over days sales outstanding (313.91) and high PB-ROE (3.88). Year-over-year operating revenue surged 616.67, indicating growth potential, yet the company must improve receivable collection and address valuation dispersion.

Fundamental(5.12)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.26
Score3/3
Weight19.90%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value616.67
Score2/3
Weight1.70%
1M Return1.11%
Days sales outstanding
Value313.91
Score1/3
Weight-2.19%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight15.87%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.88%
1M Return8.45%
PB-ROE
Value3.88
Score0/3
Weight4.74%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.59%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value616.67
Score2/3
Weight0.65%
1M Return0.43%
Asset-MV
Value-2.44
Score3/3
Weight29.42%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight15.60%
1M Return8.41%
Is IXHL undervalued or overvalued?
  • IXHL scores 5.12/10 on fundamentals and holds a Fair valuation at present. Backed by its -14.18% ROE, -398933.33% net margin, -2.13 P/E ratio, 1.29 P/B ratio, and 20.59% earnings growth, these metrics solidify its Netural investment rating.